Comparison of the relationship of age and beta cell function in three ethnic groups

Clinical Endocrinology

Volumn 62, Issue 3, 2005, Pages 296-302

  Chiu, Ken C ^a,b   Martinez, Dorothy S ^a   Chu, Audrey ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b FACE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ADULT; AFRICAN AMERICAN; AGING; ARTICLE; BODY MASS; CAUCASIAN; ETHNIC GROUP; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HEALTH SURVEY; HISPANIC; HUMAN; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PREVALENCE; PRIORITY JOURNAL; UNITED STATES;

ADULT; AFRICAN AMERICANS; AGING; BLOOD GLUCOSE; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; FASTING; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HISPANIC AMERICANS; HUMANS; INSULIN; ISLETS OF LANGERHANS; MALE; MIDDLE AGED;

EID: 15044345939     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2005.02213.x     Document Type: Article

References (29)

1. DeFronzo, R.A. (1988) Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes, 37, 667-687.
2. Groop, L.C., Widaen, E. & Ferrannini, E. (1993) Insulin resistance and insulin deficiency in the pathogenesis of type 2 (noninsulin-dependent) diabetes mellitus: errors of metabolism or of methods? Diabetologia, 36, 1326-1331.
3. Kahn, S.E. (2003) The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia, 46, 3-19.
4. Rossetti, L., Giaccari, A. & DeFronzo, R.A. (1990) Glucose toxicity. Diabetes Care, 13, 610-630.
5. Milburn, J.J., Hirose, H., Lee, Y.H. et al. (1995) Pancreatic beta-cells in obesity. Evidence for induction of functional, morphologic, and metabolic abnormalities by increased long chain fatty acids. Journal of Biological Chemistry, 270, 1295-1299.
6. Randle, P.J. (1998) Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years. Diabetes/Metabolism Reviews, 14, 263-283.
7. Boden, G. & Shulman, G.I. (2002) Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta cell dysfunction. European Journal of Clinical Investigation, 32 (Suppl. 3), 14-23.
8. Ferrannini, E. (1998) Insulin resistance versus insulin deficiency in noninsulin-dependent diabetes mellitus: problems and prospects. Endocrine Reviews, 19, 477-490.
9. Gerich, J.E. (1998) The genetic basis of type 2 diabetes mellitus: impaired insulin secretion versus impaired insulin sensitivity. Endocrine Reviews, 19, 491-503.
10. Kahn, B.B. (1998) Type 2 diabetes: when insulin secretion fails to compensate for insulin resistance. Cell, 92, 593-596.
11. Harris, M.I., Flegal, K.M., Cowie, C.C., Eberhardt, M.S., Goldstein, D.E., Little, R.R., Wiedmeyer, H.M. & Byrd-Holt, D.D. (1998) Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-94 [see comments]. Diabetes Care, 21, 518-524.
12. Colagiuri, S., Hussain, Z., Zimmet, P., Cameron, A. & Shaw, J. (2004) Screening for type 2 diabetes and impaired glucose metabolism: the Australian experience. Diabetes Care, 27, 367-371.
13. DeFronzo, R.A. (1992) Pathogenesis of type 2 (noninsulin dependent) diabetes mellitus: a balanced overview. Diabetologia, 35, 389-397.
14. Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F. & Turner, R.C. (1985) Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28, 412-419.
15. Chiu, K.C., Lee, N.P., Cohan, P. & Chuang, L.M. (2000) Beta cell function declines with age in glucose tolerant Caucasians. Clinical Endocrinology, 53, 569-575.
16. Yates, A.P. & Laing, I. (2002) Age-related increase in haemoglobin A1c and fasting plasma glucose is accompanied by a decrease in beta cell function without change in insulin sensitivity: evidence from a cross-sectional study of hospital personnel. Diabetes Medicine, 19, 254-258.
17. National Center for Health Statistics (1994) Plan and operation of the Third National Health and Nutrition Examination Survey 1988-94. Vital Health Statistics, 32, 1-470.
18. Levy, J.C., Matthews, D.R. & Hermans, M.P. (1998) Correct homeostasis model assessment (HOMA) evaluation uses the computer program [letter]. Diabetes Care, 21, 2191-2192.
19. Anonymous. (2004) Diagnosis and classification of diabetes mellitus. Diabetes Care, 27 (Suppl. 1), S5-S10.
20. Barr, R.G., Nathan, D.M., Meigs, J.B. & Singer, D.E. (2002) Tests of glycemia for the diagnosis of type 2 diabetes mellitus. Annals of International Medicine, 137, 263-272.
21. Dunstan, D.W., Zimmet, P.Z., Welborn, T.A., Cameron, A.J., Shaw, J., de Court Jolley, D. & McCarty, D.J. (2002) The Australian Diabetes, Obesity and Lifestyle Study (AusDiab) - methods and response rates. Diabetes Research and Clinical Practice, 57, 119-129.
22. Wang, W., Lee, E.T., Fabsitz, R., Welty, T.K. & Howard, B.V. (2002) Using HbA (1c) to improve efficacy of the american diabetes association fasting plasma glucose criterion in screening for new type 2 diabetes in American Indians: the strong heart study. Diabetes Care, 25, 1365-1370.
23. Monnier, L., Lapinski, H. & Colette, C. (2003) Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA (1c). Diabetes Care, 26, 881-885.
24. Chiu, K.C., Martinez, D.S., Yoon, C. & Chuang, L.M. (2002) Relative contribution of insulin sensitivity and beta-cell function to plasma glucose and insulin concentrations during the oral glucose tolerance test. Metabolism: Clinical and Experimental, 51, 115-120.
25. Hermans, M.P., Levy, J.C., Morris, R.J. & Turner, R.C. (1999a) Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes. Diabetologia, 42, 678-687.
26. Hermans, M.P., Levy, J.C., Morris, R.J. & Turner, R.C. (1999b) Comparison of tests of beta cell function across a range of glucose tolerance from normal to diabetes. Diabetes, 48, 1779-1786.
27. UKPDS. (1995) UK prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. UK Prospective Diabetes Study Group. Diabetes, 44, 1249-1258.
28. Andres, R. (1981) Aging, diabetes, and obesity: standards of normality. Mount Sinai Journal of Medicine, 48, 489-495.
29. Andres, R. & Tobin, J.D. (1975) Aging and the disposition of glucose. Advances in Experimental Medical Biology, 61, 239-249.